CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Insider Changes in Ownership
- 4 Grant or award Chief Commercial Officer acquired 67,114 shares (grant or award)
- 4 Open-market sale General Counsel sold 965 shares at $1.48 ($1,428)
- 4 Open-market sale Chief Scientific Officer sold 1,439 shares at $1.48 ($2,130)
- 4 Grant or award General Counsel acquired 3,703 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 3,703 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 6,680 shares at an average $1.44 ($9,600)
- 4 Open-market sale Chief Data Officer sold 1,311 shares at $1.48 ($1,940)
- 4 Open-market sale Chief Information Officer sold 667 shares at $1.48 ($987)
- 4 Open-market sale Chief Executive Officer sold 26,386 shares at an average $1.44 ($37,899)
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Grant or award Director acquired 15,596 shares (grant or award)
- 4 Grant or award Director acquired 15,596 shares (grant or award)
- 4 Open-market sale Director sold 107 shares at $1.58 ($169)
- 4 Grant or award Director acquired 15,596 shares (grant or award)
- 4 Grant or award Director acquired 15,596 shares (grant or award)
- 4 Grant or award Director acquired 15,596 shares (grant or award)
- 4 Grant or award Director acquired 15,596 shares (grant or award)
- 4 Open-market sale Director sold 106 shares at $2.44 ($259)
Page 6 of 16 · 313 filings